A Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEP of the European Pharmacopoeia monograph is often referred to as a Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether Certificate of Suitability (COS). The purpose of a Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether to their clients by showing that a Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEP has been issued for it. The manufacturer submits a Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEP (COS) as part of the market authorization procedure, and it takes on the role of a Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEP holder for the record. Additionally, the data presented in the Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether DMF.
A Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Allyl-1-(2,4-dichlorophenyl)-2-imidazol-1-ylethyl ether suppliers with CEP (COS) on PharmaCompass.